Cell death imaging targets in studies supporting clinical evidence | Reference(s) |
---|---|
Cardiovascular disease | |
Myocardial infarction | 2,64 |
Cardiac allograft rejection | 39 |
Heart failure | 74 |
Carotid atherosclerosis | 40 |
Oncology | |
Intracardiac tumors (malignant: 99mTc-anxA5 uptake; benign: so far no 99mTc-anxA5 uptake) | 40,79 |
Head and neck tumors | 42 |
Non-Hodgkin’s lymphoma | 43,85 |
Recurrent follicular lymphoma | 86 |
Leukemia | 87 |
Non–small cell lung cancer | 85 |
Sarcoma | 43 |
Breast cancer | 43,85 |
Cancer therapy: positive correlation between 99mTc-anxA5 uptake and therapy efficacy | 85,87 |